Joshua Jennings
Stock Analyst at TD Cowen
(3.33)
# 984
Out of 4,944 analysts
70
Total ratings
46.15%
Success rate
4.24%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUMA Humacyte | Maintains: Buy | $5 → $3.5 | $1.78 | +97.18% | 3 | Aug 12, 2025 | |
| SENS Senseonics Holdings | Initiates: Buy | $1.25 | $0.48 | +159.23% | 1 | Jul 15, 2025 | |
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $4.10 | +265.85% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $308.48 | +5.03% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $102.50 | +7.32% | 7 | Dec 12, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $36 | $11.94 | +201.63% | 2 | Dec 9, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $132.16 | -9.20% | 9 | Nov 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $2.54 | +1,870.75% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $40.40 | +145.05% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $103.27 | +15.24% | 1 | Sep 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $60 | $37.92 | +58.23% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $79.89 | +0.14% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $45 | $13.19 | +241.17% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $77.68 | -9.89% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $174.42 | +6.07% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $24.10 | +65.98% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $378.95 | +5.55% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $38.29 | +56.72% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $11.13 | +205.48% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $5.45 | +230.28% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $79.95 | +56.35% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $18.90 | +32.28% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $129.40 | +0.46% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.70 | +85.19% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $92.91 | +25.93% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $7.83 | +5,647.13% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $15.80 | -24.03% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $195.96 | +40.33% | 1 | Feb 7, 2020 |
Humacyte
Aug 12, 2025
Maintains: Buy
Price Target: $5 → $3.5
Current: $1.78
Upside: +97.18%
Senseonics Holdings
Jul 15, 2025
Initiates: Buy
Price Target: $1.25
Current: $0.48
Upside: +159.23%
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $4.10
Upside: +265.85%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $308.48
Upside: +5.03%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $102.50
Upside: +7.32%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $36
Current: $11.94
Upside: +201.63%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $132.16
Upside: -9.20%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $2.54
Upside: +1,870.75%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $40.40
Upside: +145.05%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $103.27
Upside: +15.24%
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $37.92
Upside: +58.23%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $79.89
Upside: +0.14%
Aug 8, 2024
Maintains: Buy
Price Target: $135 → $45
Current: $13.19
Upside: +241.17%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $77.68
Upside: -9.89%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $174.42
Upside: +6.07%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $24.10
Upside: +65.98%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $378.95
Upside: +5.55%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $38.29
Upside: +56.72%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $11.13
Upside: +205.48%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $5.45
Upside: +230.28%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $79.95
Upside: +56.35%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $18.90
Upside: +32.28%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $129.40
Upside: +0.46%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.70
Upside: +85.19%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $92.91
Upside: +25.93%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $7.83
Upside: +5,647.13%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $15.80
Upside: -24.03%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $195.96
Upside: +40.33%